Making Health Possible
Colon cancer is one of the most preventable forms of cancer—yet it’s the second leading cause of cancer deaths. We’re out to change that.
Through our partnership with Metabiomics, we’ve developed technology that detects biological signals associated with pre-cancerous polyps and colon cancer. Our non-invasive test analyzes an individual’s microbiome—the billions of bacteria and other microbes that live in the gut—to reveal subtle early signs of lesions that could become cancerous. We believe that through early detection and removal of these lesions we may be able to prevent cancer before it starts. This test received FDA Breakthrough Device designation in August 2019.
Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects an estimated 5 to 6 million women of childbearing age—but many don’t know they have it. It’s time for that to change.
Because women with PCOS are at higher risk of infertility and metabolic syndrome, which leads to increased risk for heart disease, diabetes, and stroke, we’re developing new technology to help improve early detection and diagnosis of PCOS. Providing early, accurate insights about PCOS to providers and patients can help support early intervention and may help prevent other chronic conditions from developing.
Partner with Us
If you are a researcher and interested in working with us, we’d love to talk.